{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:22:51Z","timestamp":1789226571377,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2745-8","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T05:48:49Z","timestamp":1473140929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Kana","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5743-0149","authenticated-orcid":false,"given":"Yusuke","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"3","key":"2745_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/modpathol.2009.180","volume":"23","author":"S Klebe","year":"2010","unstructured":"Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT, Roggli VL. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol. 2010;23(3):470\u20139.","journal-title":"Mod Pathol"},{"issue":"2","key":"2745_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/0019-5278.146897","volume":"18","author":"C Bianchi","year":"2014","unstructured":"Bianchi C, Bianchi T. Global mesothelioma epidemic: trend and features. Indian J Occup Environ Med. 2014;18(2):82\u20138.","journal-title":"Indian J Occup Environ Med"},{"issue":"1","key":"2745_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.6004\/jnccn.2012.0006","volume":"10","author":"DS Ettinger","year":"2012","unstructured":"Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, et al. Malignant pleural mesothelioma. J Natl Compr Canc Netw. 2012;10(1):26\u201341.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2745_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12199-007-0017-6","volume":"13","author":"K Inai","year":"2008","unstructured":"Inai K. Pathology of mesothelioma. Environ Health Prev Med. 2008;13(2):60\u20134.","journal-title":"Environ Health Prev Med"},{"key":"2745_CR5","first-page":"19","volume":"1","author":"MJC Kannerstein","year":"1980","unstructured":"Kannerstein MJC. Desmoplastic diffuse malignant mesothelioma. Prog Surg Pathol. 1980;1:19\u201327.","journal-title":"Prog Surg Pathol"},{"issue":"7","key":"2745_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/jcp.54.7.498","volume":"54","author":"AR Gibbs","year":"2001","unstructured":"Gibbs AR, Thunnissen FB. Histological typing of lung and pleural tumours: third edition. J Clin Pathol. 2001;54(7):498\u20139.","journal-title":"J Clin Pathol"},{"key":"2745_CR7","volume-title":"World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Chapter 3","author":"W Travis","year":"2004","unstructured":"Travis W, Brambilla W, M\u00fcller-Hermelink H, Harris C. World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Chapter 3. Lyon: IARC press; 2004."},{"issue":"3","key":"2745_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35(3):479\u201395.","journal-title":"Eur Respir J"},{"issue":"2","key":"2745_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004;15(2):257\u201360.","journal-title":"Ann Oncol"},{"issue":"3","key":"2745_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00000478-198204000-00003","volume":"6","author":"R Cantin","year":"1982","unstructured":"Cantin R, Al-Jabi M, McCaughey WT. Desmoplastic diffuse mesothelioma. Am J Surg Pathol. 1982;6(3):215\u201322.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2745_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jcp.45.4.295","volume":"45","author":"GE Wilson","year":"1992","unstructured":"Wilson GE, Hasleton PS, Chatterjee AK. Desmoplastic malignant mesothelioma: a review of 17 cases. J Clin Pathol. 1992;45(4):295\u20138.","journal-title":"J Clin Pathol"},{"issue":"6","key":"2745_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.1440-1827.2003.01488.x","volume":"53","author":"R Ishikawa","year":"2003","unstructured":"Ishikawa R, Kikuchi E, Jin M, Fujita M, Itoh T, Sawa H, Nagashima K. Desmoplastic malignant mesothelioma of the pleura: autopsy reveals asbestos exposure. Pathol Int. 2003;53(6):401\u20136.","journal-title":"Pathol Int"},{"issue":"10","key":"2745_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","volume":"22","author":"NG Ordonez","year":"1998","unstructured":"Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol. 1998;22(10):1203\u201314.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2745_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ajcp\/110.2.191","volume":"110","author":"WE Mangano","year":"1998","unstructured":"Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol. 1998;110(2):191\u20139.","journal-title":"Am J Clin Pathol"},{"key":"2745_CR15","first-page":"91","volume":"22 Pt 2","author":"VL Roggli","year":"1987","unstructured":"Roggli VL, Kolbeck J, Sanfilippo F, Shelburne JD. Pathology of human mesothelioma. Etiologic and diagnostic considerations. Pathol Annu. 1987;22 Pt 2:91\u2013131.","journal-title":"Pathol Annu"},{"issue":"1","key":"2745_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00000478-198601000-00005","volume":"10","author":"JW Bolen","year":"1986","unstructured":"Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol. 1986;10(1):34\u201347.","journal-title":"Am J Surg Pathol"},{"key":"2745_CR17","first-page":"154","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","author":"W Travis","year":"2015","unstructured":"Travis W, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart, vol. 7. 4th ed. Lyon: IARC Press; 2015. p. 154\u201381. Chapter 2.","edition":"4"},{"issue":"2","key":"2745_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V, Travis WD, World Health Organization Committee for Tumors of the P. The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11(2):142\u201354.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2745_CR19","first-page":"255","volume":"3","author":"Y Ishioka","year":"2014","unstructured":"Ishioka Y, Nakagawa H, Yamamoto K, Shimoyama A, Yagihashi N. A case of desmoplastic malignant mesothelioma diagnosed by CT-guided biopsy based on PET-CT. Ann Jpn Respir Soc. 2014;3(2):255\u20139.","journal-title":"Ann Jpn Respir Soc"},{"issue":"3","key":"2745_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.semtcvs.2013.10.004","volume":"25","author":"KE Rosenzweig","year":"2013","unstructured":"Rosenzweig KE. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2013;25(3):245\u201350.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"4","key":"2745_CR21","first-page":"337","volume":"40","author":"H Nakamura","year":"2002","unstructured":"Nakamura H, Kitada O, Aragane K, Miyata S, Kodama T, Kuribayashi K, Nakagomi T, Takenaka N, Jin S, Nagasawa M, et al. A case of desmoplastic malignant mesothelioma with elevated serum CYFRA 21\u20131. Nihon Kokyuki Gakkai Zasshi. 2002;40(4):337\u201340.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"14","key":"2745_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636\u201344.","journal-title":"J Clin Oncol"},{"issue":"10026","key":"2745_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387(10026):1405\u201314.","journal-title":"Lancet"},{"issue":"9","key":"2745_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","volume":"24","author":"GL Ceresoli","year":"2006","unstructured":"Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, et al. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol. 2006;24(9):1443\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2745_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3816\/CLC.2010.n.005","volume":"11","author":"N Katirtzoglou","year":"2010","unstructured":"Katirtzoglou N, Gkiozos I, Makrilia N, Tsaroucha E, Rapti A, Stratakos G, Fountzilas G, Syrigos KN. Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study. Clin Lung Cancer. 2010;11(1):30\u20135.","journal-title":"Clin Lung Cancer"},{"issue":"11","key":"2745_CR26","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/cncr.11405","volume":"97","author":"AG Favaretto","year":"2003","unstructured":"Favaretto AG, Aversa SM, Paccagnella A, Manzini Vde P, Palmisano V, Oniga F, Stefani M, Rea F, Bortolotti L, Loreggian L, et al. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer. 2003;97(11):2791\u20137.","journal-title":"Cancer"},{"issue":"1","key":"2745_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3816\/CLC.1999.n.006","volume":"1","author":"SM Aversa","year":"1999","unstructured":"Aversa SM, Favaretto AG. Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma: a phase II study of the GSTPV. Clin Lung Cancer. 1999;1(1):73\u20135.","journal-title":"Clin Lung Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2745-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:04:17Z","timestamp":1498327457000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2745"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2745-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]},"article-number":"718"}}